trending Market Intelligence /marketintelligence/en/news-insights/trending/b3bzr1squmqihutg5ac1pw2 content esgSubNav
In This List

Novo Nordisk adds board members

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Novo Nordisk adds board members

Bagsvaerd, Denmark-based Novo Nordisk A/S' board of directors proposed the election of Andreas Fibig and Martin Mackay as board members.

Fibig is the CEO and chairman of International Flavors & Fragrances Inc., while Mackay was formerly the executive vice president and global head of research and development at Alexion Pharmaceuticals Inc.

Both appointments will be proposed at the drugmaker's annual meeting in March.